Disc Medicine
Min Wu is currently the Vice President and Head of Innovation and Biology at Disc Medicine, a hematology company focusing on heme biosynthesis and iron metabolism for hematologic diseases. Previously, Wu has held roles such as Senior Director of Biology at Proteostasis Therapeutics, Inc., Principal Scientist/Project Leader at FORMA Therapeutics, and Associate Director of Biology at Agios Pharmaceuticals, Inc. Wu has a PhD in Genetics/Developmental Biology from the University of Tennessee, Knoxville - Oak Ridge National Laboratory.
This person is not in any teams
Disc Medicine
Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. Disc Medicine is building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.